Vistin Pharma ASA (OSL:VISTN)

Vistin Pharma ASA Revenue

Vistin Pharma ASA had revenue of 112.21M NOK in the quarter ending March 31, 2026, a decrease of -2.45%. This brings the company's revenue in the last twelve months to 449.47M, up 2.00% year-over-year. In the year 2025, Vistin Pharma ASA had annual revenue of 452.29M with 5.31% growth.

• Revenue (ttm): 449.47M
• Revenue Growth: +2.00%
• P/S Ratio: 2.21
• Revenue / Employee: 5.91M
• Employees: 77
• Market Cap: 993.32M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	452.29M	22.79M	5.31%
Dec 31, 2024	429.50M	-8.83M	-2.01%
Dec 31, 2023	438.33M	133.48M	43.78%
Dec 31, 2022	304.85M	26.23M	9.41%
Dec 31, 2021	278.62M	24.72M	9.73%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 10, 2026

Data Sources Report a data error